Welcome to thyssenkrupp nucera

14/01/22 -"thyssenkrupp is considering the IPO of its electrolysis business The proceeds would be used to finance growth, with thyssenkrupp keeping its majority A preliminary valuation of the business would ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

14/01/22

Download

You may also be interested by these reports :

31/10/25

Adyen

Q3 revenues came in better than expected, but the company guided for a reduced range of growth for 2026. Yet several items underscore the ...

31/10/25

Leonteq AG

We upgraded our target price for Leonteq, accounting for better prospects across 2025-2027, mostly helped by stronger cost-efficiency and a more ...

30/10/25

Pluxee

The FY25 results slightly exceeded consensus but fell short of our projections, with a better-than-expected recurring EBITDA margin and cash ...

29/10/25

DWS

DWS delivered strong Q3-25 results, beating consensus on higher AuM and inflows driving management fees and strong operating leverage (C/I 57%). ...

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue